Allscripts Healthcare Solutions, Inc. announced unaudited consolidated financial results for the second quarter and six months ended June 30, 2016. For the quarter, the company reported total revenues of $386.5 million compared with $351.7 million for the same period a year ago. Income from operations was $18.6 million compared with $5.6 million for the same period a year ago. Loss before income taxes was $2.6 million compared with $1.7 million for the same period a year ago. Net loss attributable to the company's stockholders was $10.2 million or $0.05 per basic and diluted share compared with $3.2 million or $0.01 per basic and diluted share for the same period a year ago. Net cash provided by operating activities was $56.2 million compared with $30.3 million for the same period a year ago. Capital expenditures were $8.8 million compared with $3.5 million for the same period a year ago. Capitalized software was $22.0 million compared with $12.4 million for the same period a year ago. Total non-GAAP operating income was $57.3 million compared with $39.1 million for the same period a year ago. Non-GAAP net income attributable to the company was $28.5 million or $0.14 per diluted share compared with $22.8 million or $0.12 per diluted share for the same period a year ago. Adjusted EBITDA was $78.1 million compared with $61.8 million for the same period a year ago.

For the six months, the company reported total revenues of $732.1 million compared with $686.3 million for the same period a year ago. Income from operations was $30.5 million compared with loss from operations of $0.1 million for the same period a year ago. Income before income taxes was $0.1 million compared with loss of $12.8 million for the same period a year ago. Net loss attributable to the company's stockholders was $8.2 million or $0.04 per basic and diluted share compared with $13.3 million or $0.07 per basic and diluted share for the same period a year ago. Net cash provided by operating activities was $132.1 million compared with $88.8 million for the same period a year ago. Capital expenditures were $16.6 million compared with $9.6 million for the same period a year ago. Capitalized software was $37.1 million compared with $21.7 million for the same period a year ago. Total non-GAAP operating income was $99.6 million compared with $64.8 million for the same period a year ago. Non-GAAP net income to the company was $53.6 million or $0.27 per diluted share compared with $37.8 million or $0.21 per diluted share for the same period a year ago. Adjusted EBITDA was $139.9 million compared with $111.7 million for the same period a year ago.

The company affirmed its prior financial guidance for 2016 as follows: Non-GAAP revenue of between $1.580 billion and $1.610 billion; adjusted net EBITDA of between $280 million and $300 million; and non-GAAP earnings per share guidance of between $0.55 and $0.62 per diluted share.